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Abstract: The presence of specific serum antibodies in five my-
asthenia gravis patients was demonstrated against the motor endplates
and muscle membranes of rats by membrane immunofluorescence
technique. The immunologic specificity of the antibodies was con·
firmed. The clinical significance is discussed.
Our previous studies on myasthenia gravis (MG) have demonstrated the
presence of serum antibodies against cross-striations (I) and muscle membrane
(2) of rat skeletal muscles. In the present paper, we report on antibodies
against the motor endplates and muscle membranes of rat skeletal muscle
using membrane immunofluorescence technique (3).
MATERIALS AND METHODS
Samples of muscle membrane were isolated from the intercostal muscles of
rats by the method descibed previously (4). The sites of the motor endplates
in the isolated muscle membrane were confirmed using methylene blue (5) or
cholinesterase staining (6).
Five MG patients were selected according to Osserman's classification (7).
There were two type IIa cases and one case each of type lIb, III and IV. Three
of these five patients had been thymectomized. Twenty ml of blood was col-
lected from each patient, and the serum separated. Gamma-G immunoglubulin
(IgG) fraction was purified from the serum by fractionation with saturated am-
monium sulfate followed by DEAE-cellulose column chromatography, and the
product was sufficiently absorbed with washed rat erythrocytes. Fluorescein
isothiocyanate (FITC) was then conjugated with purified IgG (F : P =4: I), and
the the excess was eliminated by passing the labelled immunoglobulin fraction
through a column of Sephadex G.25 to obtain the FITC-conjugated IgG. The
control material was FITC-conjugated IgG prepared from a healthy subject by
the same procedures. These FITC-conjugated IgG preparations were absorbed
with isolated muscle membranes for one hour at 37°C or 4°C to obtain absorbed
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FITC-conjugated IgG.
To locate and identify specific antibodies against the muscle membrane
and motor endplate, the isolated muscle membrane and patient serum were in-
cubated together in test tubes at 37°e, lWe or 4e'e, for graded lengths of time
(15, 30, 60 or 120 min or 12 hr). The mixtures were washed by centrifugation
with four changes of 0.1 M phosphate buffered saline iPSB), pH 7.2, and allowed
to react with the FITe-conjugated antihuman IgG for 30 min at 18°e. The
mixtures were again washed with PBS four to ten times and the resultant de-
posits were mounted on glass slides and sealed with glycerol-P BS.
In the direct immunofluorescence test, the FITe-conjugated IgG was placed
on the isolated muscle membrane, which was allowed to stand at 37°e, 18°e
or 4°e for 30 min and then washed with PBS ten times.
These slides were examined with a f1uoromicroscope INIKON), using BO
and No.1 medium filters with BV excitation. Photomicrographs were taken
with Kodak Tri-X film exposed for 2 to 5 min and developed with Pandol R at
20 0 e fot 14 min in a hypersensitizing tank.
RESULTS
In indirect membrane immunofluorescence, the entire muscle membrane
was stained green with the motor endplate of th:: membrane appearing as a
more deeply stained green structure. Green-stained terminal innervations of
the axon were occasionally observed (Fig. 1). Cross-striations of myofibrils in
rIg. J. Indirect membrane immuno:1uoresccnce. The serum
of the MG patient was sandwiched when the preparation was
stained with FITe-conjugated antihuman IgG. The entire muscle
membrane (MMI was stained green, with the motor endplate
situated on the membrane appearing as a deep green structure
(Ep). Terminal innervat ion of the axon (Til was stained green.
)~ 400.
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conjunction with muscle membrane were found stained in the same manner
(Fig. 2). In control serum, the muscle membrane was stained yellowish-
brown and the motor endplate, yellowish (Fig. 3). Preparations of serum in-
cubated for 15 or 30 min at 37°C, 18°C or 4°C were satisfactory. Those
incubated for an hour or longer emitted increased nonspecific fluorescence,
although the staining quality did not differ significantly from those incubated
Fig. 2. Indirect membrane immunofluorescence. The myo-
fibrils remaining in conjunction with the muscle membrane were
stained green at the cross-striations. X 400.
Fig. 3. Indirect membrane immunofluorescence with normal
control serum. The muscle membrane (MM) was stained to a
yellowish-brown hue and the motor endplate (Ep) to a yellowish
tone. >:400.
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for 15 or 30 min. The experiment revealed that the incubation temperature
was optimal at 4°C but adequate at 18°C. It was noted that washing with at
least four changes of PBS was essential and that the specific fluorescence did
not disappear even after washing with ten changes. When sera were diluted
with PBS, the antibody titers of thymectomized patients were from 1 : 128 to
1 : 256 in contrast to nonthymectomized patient levels of 1 : 256 (type IIa) and
1 : 1024- (type IV). Hence, higher antibody titers were present in more ad-
vanced cases.
Fig. 4. Direct membrane immunofluorescence of a myasthe-
nic patient. FITC-conjugated IgG stained the muscle membrane
IMJ"1) to a bright green. The motor endplate (Ep) was also stained
deep green. >< 400.
Fig. 5. The double-stained preparation with FITC-conju-
gated myasthenic IgG and methylene blue. The blue-stained motor
endplate (Epl emitted the characteristic fluorescence. 400.
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In direct staining with FITC-conjugated IgG of patients, the greenish
tinge of the muscle membrane became allayed and a bright, green fluorescence
resulted. The motor endplates were also stained a much deeper green (Fig. 4).
With FITC-conjugated IgG of normal subjects, the muscle membrane was
stained dark brown and the motor endplate yellow to yellowish-brown similar
to the results of indirect membrane immunofluorescence. Brighter immuno-
fluorescence in the antigen-antibody complex was more likely by incubating
the mixture at IBoC or 4°C than at 37°C.
Fig. 6. Vital staining of preparated muscle membrane with
methylene blue. Motor endplate (Ep) was stained blue. x 400.
Fig. 7. Combined staining by hematoxylin-eosin and cholin-
esterase in preparated muscle membrane. The motor endplate
(Ep) was stained yellowish-brown. >,400.
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In tests with FITC-conjugated patient IgG absorbed with muscle mem-
brane, specific fluorescence by muscle membrane was not present, and the
motor endplate was found to be stained yellowish-brown.
The double stained preparation with FITC-conjugated patient serum and
methylene blue was examined using a dark field condenser for fluorescence
microscopy and BV excitation to locate the motor endplates. The specimen
was then re-examined with an OG filter for the light source instead of the
BO filter. The blue-stained motor endplate emitted the characteristic fluo-
rescence (Fig. 5). On slides of muscle membrane stained with methylene blue
(Fig. 6) or with cholinesterase (Fig. 7), this green or yellow stained structure
was readily identified as the motor endplate from its size, shape and distribu-
tion density.
DISCUSSION
Despite the strong presumption that MG is an autoimmune disease (8),
a universal conclusion has not been reached that this condition is caused
by immunological impairment, for the following reasons: (a) autoantibodies
directed against striated muscles and against nuclei can be demonstrated only
in a small proportion of cases; (b) intramuscular infiltrations of lymphocytes
(lymphorrhages) are not necessarily extensive or marked; and (c) no specific
antibody against the motor endplate has been demonstrated in spite of the
essential abnormality and in spite of electrophysiologically impaired conduction
of the motor nerve impulse at the neuromuscular junction. Our previous
electron microscopic studies on MG patients using freeze-etched specimens
provided evidence for structural irregularity of the transverse tubule orifices
and demonstrated an increase in the diameter of particles on the surface of
the skeletal muscle (9). This suggests the possible presence of immune com-
plexes on the skeletal muscle surface. Our present findings as well as the
microscopical photographs presented by Beutner et al. (10) and by Aarli and
Closs (11) clearly demonstrate that these immune complexes result from anti-
muscle membrane antibody which is present in the serum of MG patients.
The presence of antibody activity against the motor endplates in such patients
has been speculated since 1961 (12). In 1966 Namba and Grob (13) reported
that specific immunofluorescence by structures resembling motor endplates
was observed in 2 out of 3,000 MG sera. The ultimate reason for failure of
demonstrating anti-motor endplate antibody in the past lies simply in the fact
that frozen sections of muscle were fixed in ethanol or acetone. The mem-
brane immunofluorescence technique (3) developed recently has made it
practicable to verify the presence of IgG which in the past was demonstrated
in plasma cells but not in lymphocytes. The present study represents an
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attempt to apply the same principle used in examinations of preparations of
fresh muscle membranes. Isolated muscle membranes tend to form aggre-
gates and absorb dyes nonspecifically. In tests with IgG of normal subjects,
the sites of muscle membranes and motor endplates were demonstrated by
yellowish-brown fluorescence on BV excitation, as nonspecific reaction prod-
ucts. Rat muscle membranes and motor endplates were stained specifically
by MG sera and emitted a bright green fluorescence that was clearly distin-
guishable from the fluorescence of healthy subject sera.
All MG patients reacted positively to anti-muscle membrane and anti-
motor endplate antibodies. The antibody titers were higher in advanced
cases than in earlier stages, and the titers had a tendency to decline following
the removal of the thymus. The autoantibody against muscle membrane was
found in patients with polymyositis as well as systemic lupus erythematosus.
These patients, nevertheless, showed negative results to anti-motor endplate
antibody.
Specific immunofluorescence by these antibodies has been confirmed in
the present study. Specificity was more distinct by the direct test with FITC-
conjugated IgG as compared to the serum sandwich technique, and specificity
was absent in preparations with FITC-conjugated patient IgG absorbed with
sufficient amounts of isolated muscle membrane.
It is important to determine whether the specific fluorescent positive
structures on the muscle membrane were indeed motor endplates. The motor
endplates of skeletal muscle stain blue (5) and yellowish-brown with cholin-
esterase (6). In the present study, motor endplates, identical in shape, size
and distribution density to those seen under membrane immunofluorescence
technique were confirmed on muscle membranes stained with methylene blue
or cholinesterase. Furthermore, the blue-stained motor endplates emitted
fluorescence in preparations stained directly with FITC-conjugated patient
IgG, and subsequently stained with methylene blue and examined by fluoro-
microscopy with BV excitation and OG primary filter.
The specific antibodies demonstrated against the muscle membrane and
motor endplates of skeletal muscle may be involved in the developmental fluc-
tuations, the diurnal variations and other variables operating to produce in-
consistent therapeutic responses to anticholinesterase agents and thymectomy.
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